[English] 日本語
Yorodumi
- PDB-6zhc: PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 6zhc
TitlePROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL
Components
  • Bcl-2-like protein 1
  • Elongin-B
  • Elongin-C
  • von Hippel-Lindau disease tumor suppressor
KeywordsTRANSCRIPTION / PROTAC complex / targeted degradation / ubiquitin ligase / bifunctional ligand / E3 ligase / Bcl-xL
Function / homology
Function and homology information


apoptotic process in bone marrow cell / The NLRP1 inflammasome / dendritic cell apoptotic process / dendritic cell proliferation / SARS-CoV-1-mediated effects on programmed cell death / positive regulation of mononuclear cell proliferation / regulation of cellular response to hypoxia / BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members / RHOBTB3 ATPase cycle / negative regulation of receptor signaling pathway via JAK-STAT ...apoptotic process in bone marrow cell / The NLRP1 inflammasome / dendritic cell apoptotic process / dendritic cell proliferation / SARS-CoV-1-mediated effects on programmed cell death / positive regulation of mononuclear cell proliferation / regulation of cellular response to hypoxia / BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members / RHOBTB3 ATPase cycle / negative regulation of receptor signaling pathway via JAK-STAT / negative regulation of dendritic cell apoptotic process / negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage / transcription elongation factor activity / target-directed miRNA degradation / negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway / elongin complex / negative regulation of execution phase of apoptosis / regulation of mitochondrial membrane permeability / fertilization / regulation of growth / Replication of the SARS-CoV-1 genome / VCB complex / Bcl-2 family protein complex / Cul5-RING ubiquitin ligase complex / NFE2L2 regulating tumorigenic genes / Cul2-RING ubiquitin ligase complex / intracellular membraneless organelle / response to cycloheximide / STAT5 activation downstream of FLT3 ITD mutants / hepatocyte apoptotic process / SUMOylation of ubiquitinylation proteins / cellular response to alkaloid / negative regulation of release of cytochrome c from mitochondria / negative regulation of intrinsic apoptotic signaling pathway / negative regulation of reproductive process / negative regulation of developmental process / apoptotic mitochondrial changes / germ cell development / BH3 domain binding / negative regulation of anoikis / Pausing and recovery of Tat-mediated HIV elongation / Tat-mediated HIV elongation arrest and recovery / negative regulation of transcription elongation by RNA polymerase II / HIV elongation arrest and recovery / Pausing and recovery of HIV elongation / negative regulation of extrinsic apoptotic signaling pathway in absence of ligand / ectopic germ cell programmed cell death / negative regulation of protein localization to plasma membrane / negative regulation of signal transduction / Tat-mediated elongation of the HIV-1 transcript / Formation of HIV-1 elongation complex containing HIV-1 Tat / ubiquitin-like ligase-substrate adaptor activity / negative regulation of extrinsic apoptotic signaling pathway via death domain receptors / negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway / Formation of HIV elongation complex in the absence of HIV Tat / ovarian follicle development / RNA Polymerase II Transcription Elongation / Formation of RNA Pol II elongation complex / negative regulation of TORC1 signaling / response to cytokine / extrinsic apoptotic signaling pathway in absence of ligand / RNA Polymerase II Pre-transcription Events / negative regulation of autophagy / protein serine/threonine kinase binding / release of cytochrome c from mitochondria / epithelial cell proliferation / transcription corepressor binding / regulation of cytokinesis / regulation of mitochondrial membrane potential / positive regulation of cell differentiation / TP53 Regulates Transcription of DNA Repair Genes / transcription initiation at RNA polymerase II promoter / cellular response to amino acid stimulus / transcription elongation by RNA polymerase II / Vif-mediated degradation of APOBEC3G / cellular response to gamma radiation / Inactivation of CSF3 (G-CSF) signaling / Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha / Evasion by RSV of host interferon responses / Regulation of expression of SLITs and ROBOs / male gonad development / endocytosis / cell morphogenesis / intrinsic apoptotic signaling pathway in response to DNA damage / RAS processing / ubiquitin-protein transferase activity / synaptic vesicle membrane / transcription corepressor activity / Antigen processing: Ubiquitination & Proteasome degradation / positive regulation of proteasomal ubiquitin-dependent protein catabolic process / Neddylation / channel activity / microtubule cytoskeleton / regulation of gene expression / protein-containing complex assembly / neuron apoptotic process / ubiquitin-dependent protein catabolic process / Replication of the SARS-CoV-2 genome / Interleukin-4 and Interleukin-13 signaling / spermatogenesis
Similarity search - Function
von Hippel-Lindau disease tumour suppressor, beta/alpha domain / von Hippel-Lindau disease tumour suppressor, alpha domain / von Hippel-Lindau disease tumour suppressor, beta domain / VHL superfamily / von Hippel-Lindau disease tumour suppressor, alpha domain superfamily / von Hippel-Lindau disease tumour suppressor, beta domain superfamily / VHL beta domain / VHL box domain / Apoptosis regulator, Bcl-X / Apoptosis regulator, Bcl-2/ BclX ...von Hippel-Lindau disease tumour suppressor, beta/alpha domain / von Hippel-Lindau disease tumour suppressor, alpha domain / von Hippel-Lindau disease tumour suppressor, beta domain / VHL superfamily / von Hippel-Lindau disease tumour suppressor, alpha domain superfamily / von Hippel-Lindau disease tumour suppressor, beta domain superfamily / VHL beta domain / VHL box domain / Apoptosis regulator, Bcl-X / Apoptosis regulator, Bcl-2/ BclX / Apoptosis regulator, Bcl-2, BH4 motif, conserved site / Apoptosis regulator, Bcl-2 family BH4 motif signature. / Apoptosis regulator, Bcl-2 protein, BH4 / Bcl-2 homology region 4 / Apoptosis regulator, Bcl-2 family BH4 motif profile. / BH4 Bcl-2 homology region 4 / Elongin-C / Elongin B / Apoptosis regulator, Bcl-2, BH3 motif, conserved site / Apoptosis regulator, Bcl-2 family BH3 motif signature. / Apoptosis regulator, Bcl-2, BH1 motif, conserved site / Apoptosis regulator, Bcl-2 family BH1 motif signature. / S-phase kinase-associated protein 1-like / SKP1 component, POZ domain / Skp1 family, tetramerisation domain / Found in Skp1 protein family / Apoptosis regulator, Bcl-2, BH2 motif, conserved site / Apoptosis regulator, Bcl-2 family BH2 motif signature. / Bcl-2 family / BCL (B-Cell lymphoma); contains BH1, BH2 regions / Bcl2-like / Bcl-2, Bcl-2 homology region 1-3 / Apoptosis regulator proteins, Bcl-2 family / BCL2-like apoptosis inhibitors family profile. / Bcl-2-like superfamily / SKP1/BTB/POZ domain superfamily / Ubiquitin family / Ubiquitin homologues / Ubiquitin domain profile. / Ubiquitin-like domain / Ubiquitin-like domain superfamily
Similarity search - Domain/homology
IODIDE ION / Chem-QL8 / von Hippel-Lindau disease tumor suppressor / Bcl-2-like protein 1 / Elongin-C / Elongin-B
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.92 Å
AuthorsChung, C.
CitationJournal: Acs Chem.Biol. / Year: 2020
Title: Structural Insights into PROTAC-Mediated Degradation of Bcl-xL.
Authors: Chung, C.W. / Dai, H. / Fernandez, E. / Tinworth, C.P. / Churcher, I. / Cryan, J. / Denyer, J. / Harling, J.D. / Konopacka, A. / Queisser, M.A. / Tame, C.J. / Watt, G. / Jiang, F. / Qian, D. / Benowitz, A.B.
History
DepositionJun 22, 2020Deposition site: PDBE / Processing site: PDBE
Revision 1.0Aug 5, 2020Provider: repository / Type: Initial release
Revision 1.1Sep 30, 2020Group: Database references / Category: citation
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation.title
Revision 1.2Jan 24, 2024Group: Data collection / Database references ...Data collection / Database references / Derived calculations / Refinement description
Category: atom_type / chem_comp_atom ...atom_type / chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _atom_type.pdbx_N_electrons / _atom_type.pdbx_scat_Z ..._atom_type.pdbx_N_electrons / _atom_type.pdbx_scat_Z / _database_2.pdbx_DOI / _database_2.pdbx_database_accession

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
AAA: von Hippel-Lindau disease tumor suppressor
BBB: Elongin-B
CCC: Elongin-C
DDD: Bcl-2-like protein 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)70,56143
Polymers65,8244
Non-polymers4,73639
Water8,287460
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area13990 Å2
ΔGint-6 kcal/mol
Surface area23710 Å2
MethodPISA
Unit cell
Length a, b, c (Å)70.990, 101.180, 106.930
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number19
Space group name H-MP212121

-
Components

-
Protein , 4 types, 4 molecules AAABBBCCCDDD

#1: Protein von Hippel-Lindau disease tumor suppressor / Protein G7 / pVHL


Mass: 18012.527 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: VHL / Plasmid: pET30a / Production host: Escherichia coli (E. coli) / References: UniProt: P40337
#2: Protein Elongin-B / EloB / Elongin 18 kDa subunit / RNA polymerase II transcription factor SIII subunit B / SIII p18 / ...EloB / Elongin 18 kDa subunit / RNA polymerase II transcription factor SIII subunit B / SIII p18 / Transcription elongation factor B polypeptide 2


Mass: 12088.736 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: ELOB, TCEB2 / Plasmid: pCDFDuet1 / Production host: Escherichia coli (E. coli) / References: UniProt: Q15370
#3: Protein Elongin-C / EloC / Elongin 15 kDa subunit / RNA polymerase II transcription factor SIII subunit C / SIII p15 / ...EloC / Elongin 15 kDa subunit / RNA polymerase II transcription factor SIII subunit C / SIII p15 / Transcription elongation factor B polypeptide 1


Mass: 10843.420 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: ELOC, TCEB1 / Plasmid: pCDFDuet1 / Production host: Escherichia coli (E. coli) / References: UniProt: Q15369
#4: Protein Bcl-2-like protein 1 / Bcl2-L-1 / Apoptosis regulator Bcl-X


Mass: 24879.371 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: BCL2L1, BCL2L, BCLX / Production host: Escherichia coli (E. coli) / References: UniProt: Q07817

-
Non-polymers , 5 types, 499 molecules

#5: Chemical ChemComp-QL8 / 2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]-5-[3-[4-[3-[2-[2-[2-[2-[2-[3-[[(2~{S})-3,3-dimethyl-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]amino]-3-oxidanylidene-propoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]prop-1-ynyl]phenoxy]propyl]-1,3-thiazole-4-carboxylic acid


Mass: 1329.603 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C68H80N8O14S3 / Feature type: SUBJECT OF INVESTIGATION
#6: Chemical
ChemComp-EDO / 1,2-ETHANEDIOL / ETHYLENE GLYCOL


Mass: 62.068 Da / Num. of mol.: 17 / Source method: obtained synthetically / Formula: C2H6O2
#7: Chemical
ChemComp-GOL / GLYCEROL / GLYCERIN / PROPANE-1,2,3-TRIOL


Mass: 92.094 Da / Num. of mol.: 9 / Source method: obtained synthetically / Formula: C3H8O3
#8: Chemical
ChemComp-IOD / IODIDE ION


Mass: 126.904 Da / Num. of mol.: 12 / Source method: obtained synthetically / Formula: I
#9: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 460 / Source method: isolated from a natural source / Formula: H2O

-
Details

Has ligand of interestY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.95 Å3/Da / Density % sol: 58.36 %
Crystal growTemperature: 291 K / Method: vapor diffusion / pH: 6.5
Details: 0.2 M Potassium iodide, 0.1 M MES pH 6.5, 23% PEG 4000

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: CLSI / Beamline: 08ID-1 / Wavelength: 1.0332 Å
DetectorType: DECTRIS PILATUS3 6M / Detector: PIXEL / Date: Feb 15, 2018
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.0332 Å / Relative weight: 1
ReflectionResolution: 1.92→47.27 Å / Num. obs: 59379 / % possible obs: 99.9 % / Redundancy: 6.5 % / Rmerge(I) obs: 0.079 / Net I/σ(I): 15.1
Reflection shellResolution: 1.92→1.97 Å / Redundancy: 5.7 % / Rmerge(I) obs: 0.638 / Mean I/σ(I) obs: 2.5 / Num. unique obs: 3945 / % possible all: 99.6

-
Processing

Software
NameVersionClassification
REFMAC5.8.0257refinement
XDSdata reduction
Aimlessdata scaling
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 1LM8,1MAZ

1lm8

1maz


Resolution: 1.92→47.27 Å / Cor.coef. Fo:Fc: 0.963 / Cor.coef. Fo:Fc free: 0.958 / SU B: 2.726 / SU ML: 0.078 / Cross valid method: FREE R-VALUE / ESU R: 0.119 / ESU R Free: 0.112
Details: Hydrogens have been added in their riding positions
RfactorNum. reflection% reflection
Rfree0.1957 2910 4.901 %
Rwork0.1694 56468 -
all0.171 --
obs-59378 99.802 %
Solvent computationIon probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: BABINET MODEL PLUS MASK
Displacement parametersBiso mean: 33.4 Å2
Baniso -1Baniso -2Baniso -3
1-0.019 Å20 Å2-0 Å2
2---0.039 Å20 Å2
3---0.02 Å2
Refinement stepCycle: LAST / Resolution: 1.92→47.27 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms3957 0 227 460 4644
Refine LS restraints
Refine-IDTypeDev idealDev ideal targetNumber
X-RAY DIFFRACTIONr_bond_refined_d0.0040.0134429
X-RAY DIFFRACTIONr_bond_other_d0.0020.0174120
X-RAY DIFFRACTIONr_angle_refined_deg1.2521.6815991
X-RAY DIFFRACTIONr_angle_other_deg1.191.5999571
X-RAY DIFFRACTIONr_dihedral_angle_1_deg6.4185530
X-RAY DIFFRACTIONr_dihedral_angle_2_deg32.71821.529242
X-RAY DIFFRACTIONr_dihedral_angle_3_deg12.85815724
X-RAY DIFFRACTIONr_dihedral_angle_4_deg19.6741536
X-RAY DIFFRACTIONr_chiral_restr0.0550.2543
X-RAY DIFFRACTIONr_gen_planes_refined0.0050.024892
X-RAY DIFFRACTIONr_gen_planes_other0.0010.02951
X-RAY DIFFRACTIONr_nbd_refined0.1940.2858
X-RAY DIFFRACTIONr_symmetry_nbd_other0.1750.23707
X-RAY DIFFRACTIONr_nbtor_refined0.1610.22068
X-RAY DIFFRACTIONr_symmetry_nbtor_other0.0850.21765
X-RAY DIFFRACTIONr_xyhbond_nbd_refined0.1650.2414
X-RAY DIFFRACTIONr_symmetry_xyhbond_nbd_other0.3130.21
X-RAY DIFFRACTIONr_symmetry_nbd_refined0.2190.214
X-RAY DIFFRACTIONr_nbd_other0.2120.267
X-RAY DIFFRACTIONr_symmetry_xyhbond_nbd_refined0.1510.224
X-RAY DIFFRACTIONr_mcbond_it2.414.3042054
X-RAY DIFFRACTIONr_mcbond_other2.4064.3032053
X-RAY DIFFRACTIONr_mcangle_it3.6379.6332588
X-RAY DIFFRACTIONr_mcangle_other3.6369.6362589
X-RAY DIFFRACTIONr_scbond_it3.2964.8982375
X-RAY DIFFRACTIONr_scbond_other3.2954.92376
X-RAY DIFFRACTIONr_scangle_it5.20510.5993392
X-RAY DIFFRACTIONr_scangle_other5.20410.6023393
X-RAY DIFFRACTIONr_lrange_it7.32940.1695102
X-RAY DIFFRACTIONr_lrange_other7.1739.4724970
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
1.92-1.970.2792010.2434101X-RAY DIFFRACTION99.3993
1.97-2.0240.2462340.2264014X-RAY DIFFRACTION99.812
2.024-2.0820.232020.2063883X-RAY DIFFRACTION100
2.082-2.1460.2332420.193784X-RAY DIFFRACTION100
2.146-2.2170.1922280.1783638X-RAY DIFFRACTION99.9741
2.217-2.2950.2121870.1623592X-RAY DIFFRACTION99.9735
2.295-2.3810.2251570.1633464X-RAY DIFFRACTION99.9724
2.381-2.4780.2151750.1623317X-RAY DIFFRACTION99.8856
2.478-2.5880.1991570.1673215X-RAY DIFFRACTION99.8815
2.588-2.7140.1861640.1623039X-RAY DIFFRACTION99.9376
2.714-2.8610.1821460.1582929X-RAY DIFFRACTION99.8701
2.861-3.0340.2071340.1532765X-RAY DIFFRACTION99.8278
3.034-3.2430.1861230.1672621X-RAY DIFFRACTION99.6007
3.243-3.5030.2191110.1682439X-RAY DIFFRACTION99.6873
3.503-3.8360.1931150.1632236X-RAY DIFFRACTION99.8302
3.836-4.2870.15930.1482075X-RAY DIFFRACTION99.7699
4.287-4.9480.15770.1371833X-RAY DIFFRACTION99.5829
4.948-6.0530.185790.1791544X-RAY DIFFRACTION99.4485
6.053-8.5310.211500.1981247X-RAY DIFFRACTION99.6925
8.531-47.270.174350.174732X-RAY DIFFRACTION98.3333

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more